ClinicalTrials.gg
RecruitingNCT07217769EONNUpdated Jun 3, 2026

Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

An interventional study of No-nap and 15-min nap in Shift Work, sponsored by University of Pittsburgh. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 30 studies in Idiopathic Hypersomnia with a site in United States — 12 open to participants now, 13 under way, 4 of them phase 3. Idiopathic Hypersomnia · United States.

Planned enrollment
9th of 27
130 · median 100
Started
2026
with 3 others
No phase
4 of 30
1 open now
Primary completion
2030-08
later than 10 of 12 live
Registered
27th of 30
by date

Among the 30 studies in Idiopathic Hypersomnia with a site in United States, this one is the 9th largest by planned enrollment of the 27 interventional ones that give a count, is one of 4 that started in 2026, is one of 4 with no phase, reaches primary completion later than 10 of the 12 other live ones, and was the 27th registered.

Idiopathic Hypersomnia

53 studies on the registry are indexed under Idiopathic Hypersomnia; 24 are open to participants now.

Browse Idiopathic Hypersomnia studies →

Open to participants now

12 of the 30 studies in Idiopathic Hypersomnia with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 17 Idiopathic Hypersomnia studies recruiting now, 4 (24%) set no upper age limit and 12 (71%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Idiopathic Hypersomnia with a site in United States, or all of them as a file.
02

Study summary

Night shift work schedules disrupt sleep and have a negative impact on cardiovascular health. Most who work in public safety occupations and in healthcare work night shifts. These workers experience abnormal blood pressure during night shifts and are at greater risk of cardiovascular disease. Napping during night shifts can help to restore blood pressure patterns to a more normal pattern and may help to reduce risk of cardiovascular disease. Naps may also have an impact on alertness and performance immediately upon waking. The overarching goal of this study is to determine which duration of a nap taken during simulated night shift work has the greatest impact blood pressure and post-nap performance.

Researchers will compare 5 nap durations to see which has the greatest impact on blood pressure patterns and post-nap psychomotor performance.

Researchers hypothesize that longer naps will lead to improved blood pressure outcomes and shorter naps will contribute to better performance after waking.

Findings will help employers and employees who work night shifts determine how best to incorporate brief naps during night shift work.

Read the detailed description

Blunted blood pressure (BP) dipping is a well-described risk factor for cardiovascular disease (CVD) among older adults and individuals with chronic disease. Previous research shows that night shift workers are at risk and repeatedly exposed to blunted BP dipping as a consequence of sleep loss and irregular sleep. While occasional episodes of blunted BP dipping may not be harmful, repetitive exposure over years of night shift work, as experienced by public safety workers (PSWs) and healthcare workers (HCWs), is likely detrimental to cardiovascular health and increases risk of CVD. Recent research shows that exposure can be mitigated with brief on-duty naps, which briefly restore normal BP dipping. Despite these data, there is legitimate clinical equipoise regarding the optimal on-duty nap duration (dose) needed to maximize BP dipping and minimize threats to post-nap psychomotor performance (i.e., sleep inertia).

This study will use a Phase II, within subject, crossover, incomplete block randomized trial design to test the efficacy of 5 overnight on-duty nap conditions: no-nap, 15, 30, 45, and 60-minutes. The primary outcome is the proportion of participants with a clinically meaningful greater than or equal to 10% dip in BP during nap opportunities. The secondary outcome is focused on deficits in psychomotor performance at greater than or equal to 10 mins post-nap: a safety-critical moment for PSWs and HCWs.

Goal enrollment is set at 130, accounting for attrition. Each condition begins with 36 hours of at-home monitoring with non-invasive devices. The last 12 hours of each condition includes a 12-hour simulated night shift with nap opportunities provided at 0200 hours with the nap duration determined by the randomization schema. During the simulated night shift, participants will be continuously monitored with non-invasive devices, allowed to consume controlled amounts of caffeine, and complete standardized tests of psychomotor performance. Participants will be blinded to nap duration and caffeine dose. Volunteer participants will be asked to complete 4 of the 5 nap conditions.

03

Conditions studied

  • Shift Work

Browse trials for

Keywords

  • Night shift
  • Sleep
  • Napping
  • Blood pressure
  • Psychomotor performance
  • Sleep inertia
  • Caffeine
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • non-pregnant adults (>18 years of age)
  • certified public safety/healthcare shift worker
  • is an active shift worker
  • resides within the Western Pennsylvania region within reasonable driving distance

Exclusion criteria

Exclusion Criteria:

  • current use of medication for cardiovascular disease (e.g., hypertension)
  • prior or current diagnosis of sleep apnea, narcolepsy, restless leg syndrome, ischemic heart disease, heart failure, stroke, chronic kidney disease, chronic liver disease, rheumatologic disease requiring prescription medication, and cancer requiring treatment in past 2 years
  • undiagnosed severe sleep apnea (Apnea-Hypopnea Index >30) based on at-home test
  • Abstains from caffeine or reports adverse effects from caffeine use
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
130 participants (estimated)

Study arms

  • Other
    Napping order

    5 x 4 x 3 x 2 = 120 possible orderings of the 5 interventions for each person.

    Behavioral: No-nap · Behavioral: 15-min nap · Behavioral: 30-min nap · Behavioral: 45-min nap · Behavioral: 60-min nap

Interventions

  • BehavioralNo-nap

    No-nap opportunity offered

  • Behavioral15-min nap

    A 15-minute nap opportunity at 02:00am

  • Behavioral30-min nap

    A 30-minute nap opportunity at 02:00am

  • Behavioral45-min nap

    A 45-minute nap opportunity at 02:00am

  • Behavioral60-min nap

    A 60-minute nap opportunity at 02:00am

06

What researchers measure

Primary outcomes

  1. BP dipping

    The ratio of mean sleep to mean wake blood pressure (BP) by taking the difference between the mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) during nap opportunities, and the mean SBP and DBP during wake periods.

    Time frame: During simulated night shift, 12 hours

  2. Psychomotor performance post-nap

    Severe psychomotor impairment post-nap as measured by the Psychomotor Vigilance Test Brief (PVT-B)

    Time frame: During simulated night shift, greater than or equal to 10 minutes post intervention nap

Secondary outcomes

  1. Performance on simulated patient scenarios

    Change in performance pre-to-post nap. Performance rated from 0-100 with higher scores indicating better performance. Positive change indicates improved performance.

    Time frame: During simulated night shift, 12 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All collected IPD

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: No later than 3 years after completing the last follow-up of the last participant.

Access criteria: Access through NHLBI BioLINCC repository

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Aug 2030, 51 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2025
First posted
Oct 16, 2025
StartActual
May 7, 2026
Primary completionEst.
Aug 31, 2030
CompletionEst.
Aug 31, 2030
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07217769
Responsible party
Daniel Patterson, PhD, NRP (Professor, University of Pittsburgh) — Principal investigator
First posted
Oct 16, 2025
Start date
May 7, 2026
Primary completion
Aug 31, 2030 (estimated)
Completion
Aug 31, 2030 (estimated)
Last update
Jun 3, 2026

Study contacts

Daniel Patterson, PhD
Contact
pdp3@pitt.edu
412-647-3078
Maureen Morgan
Contact
mam84@pitt.edu
412-647-3078
Daniel Patterson
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion